Monositin HDL Kolesterole Oranının Kardiyak Sendrom X ve Sistemik İnflamasyon ile İlişkisi

Yıl 2016, Cilt: 19 Sayı: 2, 97 - 102, 01.08.2016

Elnur Alizade Anıl Avcı Ahmet Güner Mehmet Mustafa Tabakcı Regayip Zehir Ahmet Güler Servet İzci Selçuk Pala

Öz

Giriş:
Bu çalışmanın amacı, kardiyak sendrom X (KSX)
hastalarında monositin HDL kolesterole oranı (MHO)’nı ve kolay kullanılabilir
inflamatuvar göstericileri araştırmaktır.

Hastalar
ve Yöntem: Çalışmaya 50’si KSX ve 50’si
normal koroner arterlere sahip toplam 100 hasta dahil edilmiştir.

Bulgular:
Total beyaz küre sayısı, nötrofil sayısı, monosit
sayısı, lenfosit sayısı, nötrofil/lenfosit oranı, C-reaktif protein, hsCRP ve
MHO KSX grubunda artmıştır (p< 0.05), ancak HDL kolesterol CSX hastalarında
kontrol grubuna göre azalmıştır (p< 0.05). Korelasyon analizinde
MHO’nun  hsCRP (r= 0.375, p< 0.001) ve
CRP (r= 0.403, p< 0.001) ile pozitif yönde korelasyon olduğu
gösterilmiştir.  Multivariate logistic
regresyon analizinde MHO’nun KSX hastalığını göstermede bağımsız bir gösterge
olduğu bulundu [odds ratio: 1.250, 95% confidence interval (CI): 1.240-1.461,
p< 0.001]. Sınır değeri 90.6 alırsak, MHO bu oran ile KSX hastalığının
varlığını %78 duyarlılık ve %70 özgüllükle göstermektedir.

Sonuç: Çalışmamızda MHO KSX hastalarını
göstermede ciddi ve bağımsız bir gösterge olduğu gösterilmiştir.

Anahtar Kelimeler

Kardiyak sendrom X, monositin HDL kolesterole oranı, inflamatuvar göstergeler

Association of Monocyte-to-HDL Cholesterol Ratio with Cardiac Syndrome X is Linked to Systemic Inflammation

Öz

Introduction:
The aim of this study was to investigate an easily
available inflammatory marker and monocyte-to-high-density lipoprotein
cholesterol ratio (MHR) in patients with cardiac syndrome X (CSX).

Patients
and Methods: The study population included 100 patients of
which 50 had CSX (CSX group) and 50 had normal coronary angiograms (control
group).

Results: Total
white blood cell (WBC) count, monocyte count, neutrophil count, NLR,
high-sensitivity C-reactive protein (hs-CRP), C-reactive protein (CRP) and MHR
were higher in the CSX group (p< 0.05), whereas high-density lipoprotein
cholesterol (HDL-C) level was significantly lower in the CSX group as compared
with that in the control group (p< 0.05). In the correlation analysis, MHR
revealed a significantly positive correlation with hs-CRP (r= 0.375, p<
0.001) and CRP (r= 0.403, p< 0.001). In the multivariate logistic regression
analysis, MHR was independently associated with the presence of CSX (odds
ratio: 1.250, 95% confidence interval [CI]: 1.240-1.461, p< 0.001). Using a
cut-off level of 90.6, pre-procedural MHR predicted the presence of slow
coronary flow (SCF) with a sensitivity of 78% and specificity of 70%.

Conclusion: In conclusion, our findings
revealed that higher MHR levels were significantly and independently associated
with the presence of CSX.

Anahtar Kelimeler

Cardiac syndrome X, monocyte-to-HDL cholesterol ratio, inflammatory markers

Kaynakça

• 1. Kaski JC, Rosano GM, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995;25:807-14.
• 2. Scholz M, Wegener K, Unverdorben M, Kleipzig H. Long-term outcome in patients with angina-like chest pain and normal coronary angiograms [in German]. Herz 2003; 28:413-20.
• 3. Bugiardini R, Manfrini O, Pizzi C, Fontana F, Morgagni G. Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation 2004; 109:2518-23.
• 4. Al Suwaıd J, Hıgano ST, Holmes Dr JR, Lerman A. Pathophysiology, diagnosis, and current management strategies for chest pain in patients with normal findings on angiography. Mayo Clin Proc 2001;76:813-22.
• 5. Hurst T, Olson TH, Olson LE, Appleton CP. Cardiac syndrome X and endothelial dysfunction: new concepts in prognosis and treatment. Am J Med 2006;119:560-6.
• 6. Luo C, Li Y, Liu D, Hu C, Du Z. The association of brachial flow-mediated dilatation and high-sensitivity C-reactive protein levels with Duke treadmill score in patients with suspected microvascular angina. Exp Clin Cardiol 2012;17:197-201.
• 7. Recio-Mayoral A, Rimoldi OE, Camci PG, Kaski JC. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC Cardiovasc Imaging 2013;6:660-7.
• 8. Ancuta P, Wang J, Gabuzda D. CD16+ monocytes produce IL-6, CCL2, and matrix metalloproteinase-9 upon interaction with CX3CL1- expressing endothelial cells. J Leukoc Biol 2006;80:1156e1164.
• 9. Hessler JR, Robertson AL, Chisolm GM. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 1979;32:213e229.
• 10. Li XP, Zhao SP, Zhang XY, Liu L, Gao M, Zhou QC. Protective effect of high density lipoprotein on endothelium-dependent vasodilatation. Int J Cardiol 2000;73:231e236.
• 11. Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, et al. Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease. Int Urol Nephrol 2014;46:1619e1625.
• 12. Canpolat U, Aytemir K, Yorgun H, Şahiner L, Kaya EB, Çay S, et al. The role of preprocedural monocyte-to-high-density lipoprotein ratio in prediction of atrial fibrillation recurrence after cryoballoon-based catheter ablation. Europace 2015;pii:euu291.
• 13. Canpolat U, Çetin EH, Cetin S, Aydin S, Akboga MK, Yayla C, et al. Association of monocyte-to-HDL cholesterol ratio with slow coronary flow is linked to systemic inflammation. Clin Appl Thromb Hemost 2015; pii: 1076029615594002.
• 14. Karataş MB, Çanga Y, Özcan KS, İpek G, Güngör B, Onuk T, et al. Monocyte to high-density lipoprotein ratio as a newprognosticmarker in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Emerg Med 2015 Oct 27. pii: S0735-6757(15)00939-0. doi: 10.1016/j.ajem.2015.10.049
• 15. Demirkol S, Balta S, Unlu M, Arslan Z, Cakar M, Kucuk U, et al. Neutrophils/lymphocytes ratio in patients with cardiac syndrome X and its association with carotid intima-media thickness. Clin Appl Thromb Hemost 2014; 20:250-5.
• 16. Tenekecıoğlu E, Yılmaz M, Demır S, Bekler A, Ozluk OA, Aydın U, et al. Lower hdl-cholesterol is associated with systemic inflammation in cardiac syndrome X. Minerva Med 2014 Jul 16.
• 17. Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E. Monocytes in coronary artery disease and atherosclerosis: where are we now? J Am Coll Cardiol 2013;62:1541-51.
• 18. Gratchev A, Sobenin I, Orekhov A, Kzhyshkowska J. Monocytes as a diagnostic marker of cardiovascular diseases. Immunobiology 2012;217:476-82.
• 19. Murphy AJ, Chin-Dusting JP, Sviridov D, Woollard KJ. The anti inflammatory effects of high density lipoproteins. Curr Med Chem 2009;16:667-75.
• 20. Murphy AJ, Woollard KJ. High-density lipoprotein: a potent inhibitor of inflammation. Clin Exp Pharmacol Physiol 2010;37:710-8.
• 21. Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. High-density lipoproteins inhibit cytokine-induced expression of endothelial, cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995;15:1987-94.
• 22. Murphy AJ, Woollard KJ, Hoang A, Mukhamedova N, Stirzaker RA, McCormick SP, et al. High density lipoprotein reduces the human monocyte inflammatory response. Arterioscler Thromb Vasc Biol 2008;28:2071-7.
• 23. Burke AP, Farb A, Malcom GT, Liang YH, Smialek J, Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 1997;336:1276-82.
• 24. Kundi H, Gok M, Kiziltunc E, Cetin M, Cicekcioglu H, Cetin ZG, et al. Relation between monocyte to high-density lipoprotein cholesterol ratio with presence and severity of isolated coronary artery ectasia. Am J Cardiol 2015;116:1685-9. doi: 10.1016/j.amjcard.2015.08.036.